SK286618B6 - Hydrát 5-[4-[2-N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jeho výroby, farmaceutický prípravok s jeho obsahom a jeho použitie - Google Patents

Hydrát 5-[4-[2-N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jeho výroby, farmaceutický prípravok s jeho obsahom a jeho použitie Download PDF

Info

Publication number
SK286618B6
SK286618B6 SK917-2000A SK9172000A SK286618B6 SK 286618 B6 SK286618 B6 SK 286618B6 SK 9172000 A SK9172000 A SK 9172000A SK 286618 B6 SK286618 B6 SK 286618B6
Authority
SK
Slovakia
Prior art keywords
hydrate
pyridyl
ethoxy
methyl
amino
Prior art date
Application number
SK917-2000A
Other languages
English (en)
Slovak (sk)
Other versions
SK9172000A3 (en
Inventor
Paul David James Blackler
David C. Lee
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of SK9172000A3 publication Critical patent/SK9172000A3/sk
Publication of SK286618B6 publication Critical patent/SK286618B6/sk

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/425—Thiazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
SK917-2000A 1997-12-16 1998-12-14 Hydrát 5-[4-[2-N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jeho výroby, farmaceutický prípravok s jeho obsahom a jeho použitie SK286618B6 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9726566.4A GB9726566D0 (en) 1997-12-16 1997-12-16 Novel pharmaceutical
PCT/EP1998/008155 WO1999031095A1 (en) 1997-12-16 1998-12-14 5-[4-[2- (n-methyl-n- (2-pyridyl)amino) ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical

Publications (2)

Publication Number Publication Date
SK9172000A3 SK9172000A3 (en) 2001-01-18
SK286618B6 true SK286618B6 (sk) 2009-02-05

Family

ID=10823692

Family Applications (1)

Application Number Title Priority Date Filing Date
SK917-2000A SK286618B6 (sk) 1997-12-16 1998-12-14 Hydrát 5-[4-[2-N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jeho výroby, farmaceutický prípravok s jeho obsahom a jeho použitie

Country Status (35)

Country Link
EP (2) EP1661895A1 (OSRAM)
JP (1) JP2002508373A (OSRAM)
KR (1) KR100549142B1 (OSRAM)
CN (3) CN1281453A (OSRAM)
AP (1) AP1365A (OSRAM)
AR (1) AR017214A1 (OSRAM)
AU (1) AU1967999A (OSRAM)
BG (1) BG64988B1 (OSRAM)
BR (1) BR9813600A (OSRAM)
CA (1) CA2314107A1 (OSRAM)
CO (1) CO4980880A1 (OSRAM)
CZ (1) CZ299965B6 (OSRAM)
DZ (1) DZ2681A1 (OSRAM)
EA (1) EA004260B1 (OSRAM)
EG (1) EG22337A (OSRAM)
GB (1) GB9726566D0 (OSRAM)
HR (1) HRP20000408B1 (OSRAM)
HU (1) HUP0100509A3 (OSRAM)
IL (1) IL136424A (OSRAM)
IN (1) IN192487B (OSRAM)
MA (1) MA26580A1 (OSRAM)
MY (1) MY135612A (OSRAM)
NO (1) NO317254B1 (OSRAM)
OA (1) OA11766A (OSRAM)
PE (1) PE20000058A1 (OSRAM)
PL (1) PL341146A1 (OSRAM)
RS (1) RS50126B (OSRAM)
SA (1) SA99191115B1 (OSRAM)
SK (1) SK286618B6 (OSRAM)
TR (2) TR200001799T2 (OSRAM)
TW (1) TW509690B (OSRAM)
UA (1) UA72198C2 (OSRAM)
UY (2) UY25308A1 (OSRAM)
WO (1) WO1999031095A1 (OSRAM)
ZA (1) ZA9811506B (OSRAM)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9726568D0 (en) 1997-12-16 1998-02-11 Smithkline Beecham Plc Novel pharmaceutical
US6664278B2 (en) 1997-12-16 2003-12-16 Smithkline Beecham P.L.C. Hydrate of 5-[4-[2-(N-methyl-N-(2-pyridil)amino)ethoxy]benzyl]thiazolidine-2,4-dione maleic acid salt
GB9909041D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
PL351684A1 (en) * 1999-04-23 2003-06-02 Smithkline Beecham Plc Polymorph of 5−[4−[2− (n−methyl−n−( 2−pyridyl)amino) ethoxy]benzyl] thiazolidine−2,4−dione, maleic acid salt
AU765498B2 (en) * 1999-04-23 2003-09-18 Smithkline Beecham Plc Novel pharmaceutical
HK1045152A1 (zh) * 1999-04-23 2002-11-15 Smithkline Beecham Plc 噻唑烷二酮衍生物及其用作抗糖尿病藥的應用
HUP0300475A3 (en) * 2000-04-25 2004-10-28 Kyorin Seiyaku Kk Novel stable crystal of thiazolidinedione derivative and process for producing the same
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
GB0021784D0 (en) * 2000-09-05 2000-10-18 Smithkline Beecham Plc Novel pharmaceutical
GB0021978D0 (en) * 2000-09-07 2000-10-25 Smithkline Beecham Plc Novel pharmaceutical
AU2001291232B8 (en) * 2000-09-26 2006-12-21 Dr. Reddy's Laboratories Limited Novel polymorphic forms of 5-[4-[2-[N-methyl-N-(2-pyridyl)amino]ethoxy]benzyl] thiazolidine-2,4-dione maleate and process for their preparation
MXPA03002580A (es) * 2000-09-26 2003-10-15 Cord Janet I Nuevas formas polimorficas de maleato de 5-(4-(2-(n-metil-n-(2-piridil) amino)etoxi)bencil) tiazolidin-2, 4-diona y proceso para su preparacion.
GB0129876D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
GB0129872D0 (en) * 2001-12-13 2002-02-06 Smithkline Beecham Plc Novel pharmaceutical
AU2002350965A1 (en) * 2001-12-13 2003-06-23 Smithkline Beecham Plc Toluenesulfonate hydrates of a thiazolidinedione derivative
GB2405403A (en) * 2003-08-29 2005-03-02 Cipla Ltd Rosiglitazone maleate of particular polymorphic forms and methods of preparing rosiglitazone free base
ITMI20041537A1 (it) * 2004-07-28 2004-10-28 Chemi Spa Nuova forma polimorfa del rosiglitazone maleato
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP2184055A1 (en) 2008-11-07 2010-05-12 LEK Pharmaceuticals d.d. Process for preparing solid dosage forms of rosiglitazone maleate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE186724T1 (de) * 1987-09-04 1999-12-15 Beecham Group Plc Substituierte thiazolidindionderivate
GB8820389D0 (en) * 1988-08-26 1988-09-28 Beecham Group Plc Novel compounds
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
JPH09512249A (ja) * 1994-02-10 1997-12-09 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー 腎臓疾患を治療するためのインスリンセンシタイザーの使用

Also Published As

Publication number Publication date
AP2000001831A0 (en) 2000-06-30
ZA9811506B (en) 2000-11-06
RS50126B (sr) 2009-03-25
CN101302215A (zh) 2008-11-12
CZ299965B6 (cs) 2009-01-07
CZ20002204A3 (cs) 2000-11-15
BG104603A (en) 2001-03-30
HRP20000408B1 (hr) 2008-04-30
AU1967999A (en) 1999-07-05
GB9726566D0 (en) 1998-02-11
IN192487B (OSRAM) 2004-04-24
BR9813600A (pt) 2000-10-10
TR200001799T2 (tr) 2001-01-22
SA99191115B1 (ar) 2006-10-11
IL136424A0 (en) 2001-06-14
UY25308A1 (es) 1999-07-19
HUP0100509A3 (en) 2002-06-28
EG22337A (en) 2002-12-31
SK9172000A3 (en) 2001-01-18
CN1281453A (zh) 2001-01-24
PE20000058A1 (es) 2000-02-26
YU36300A (sh) 2004-03-12
MY135612A (en) 2008-05-30
TW509690B (en) 2002-11-11
TR199802625A2 (xx) 1999-10-21
CA2314107A1 (en) 1999-06-24
OA11766A (en) 2005-07-19
NO317254B1 (no) 2004-09-27
AR017214A1 (es) 2001-08-22
EA004260B1 (ru) 2004-02-26
MA26580A1 (fr) 2004-12-20
UA72198C2 (en) 2005-02-15
NO20003069D0 (no) 2000-06-15
KR20010033141A (ko) 2001-04-25
IL136424A (en) 2003-12-10
CO4980880A1 (es) 2000-11-27
KR100549142B1 (ko) 2006-02-03
EP1661895A1 (en) 2006-05-31
AP1365A (en) 2005-01-26
HUP0100509A2 (hu) 2002-05-29
BG64988B1 (bg) 2006-11-30
NO20003069L (no) 2000-06-15
PL341146A1 (en) 2001-03-26
CN101381367A (zh) 2009-03-11
TR199802625A3 (tr) 1999-10-21
JP2002508373A (ja) 2002-03-19
WO1999031095A1 (en) 1999-06-24
HRP20000408A2 (en) 2000-08-31
EP1040110A1 (en) 2000-10-04
EA200000654A1 (ru) 2000-12-25
DZ2681A1 (fr) 2004-06-20
UY25304A1 (es) 2000-12-29

Similar Documents

Publication Publication Date Title
SK286422B6 (sk) Hydrát 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-dión maleínanu, spôsob jehovýroby, farmaceutický prípravok s jeho obsahom a jeho použitie
US20070203200A1 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl]thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical
SK9172000A3 (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2,4-dione, maleic acid salt, hydrate as pharmaceutical
ES2203453T3 (es) Polimorfo de sal del acido maleico de 5-(4-(2-(n-metil-n-(2-piridil)amino)etoxi)bentil)tiazolidina-2,4-diona.
SK286399B6 (sk) V podstate nehydratovaná a nehygroskopická alebo iba mierne hygroskopická hydrochloridová soľ 5-[4-[2-(N-metyl-N-(2- pyridyl)amino)etoxy]benzyl]tiazolidín-2,4-diónu, spôsob jej prípravy, farmaceutický prostriedok s jej obsahom a jej použitie
KR20020028873A (ko) 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
SK9102000A3 (en) Hydrate of 5-[4-[2-(n-methyl-n-(2-pyridil)amino) ethoxy]benzyl]-thiazolidine-2,4-dione maleic acid salt
KR20010110804A (ko) 티아졸리딘디온 유도체 및 항당뇨병제로서 그의 용도
CZ300653B6 (cs) Dihydrát 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl}thiazolidin-2,4-dion-hydrochloridu, zpusob jeho prípravy a použití a farmaceutický prostredek s jeho obsahem
CZ300934B6 (cs) Monohydrát 5-{4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl}thiazolidin-2,4-dion-hydrochloridu, zpusob jeho výroby, farmaceutický prostredek s jeho obsahem a použití
CZ302125B6 (cs) Hydrochloridová sul 5- [4-[2-(N-methyl-N-(2-pyridyl)amino)ethoxy]benzyl]thiazolidin-2,4-dionu, zpusob její prípravy a farmaceutická kompozice s jejím obsahem
AU770817B2 (en) 5-(4-(2-(N-methyl-N-(2-pyridyl)amino)ethoxy)benzyl) thiazolidine-2,dione,maleic acid salt, hydrate as pharmaceutical
HK1092138A (en) 5-[4-[2-(n-methyl-n-(2-pyridyl)amino)ethoxy]benzyl] thiazolidine-2, 4-dione, maleic acid salt, hydrate as pharmaceutical

Legal Events

Date Code Title Description
MM4A Patent lapsed due to non-payment of maintenance fees

Effective date: 20101214